| Transaction |
Landmark Capital acted as exclusive financial advisor of União Química Farmacêutica Nacional, one of Brazil´s leading pharmaceutical company, in the structuring and negotiation of a long term manufacture agreement of Novartis medicines, one of world´s largest pharmaceutical company, at Taboão da Serra/SP facility. This plant manufactures medicines to supply the Latin American market. Besides the manufacturing agreement, the transaction also included the acquisition of Taboão da Serra/SP facility by União Química. |
